---
title: Dipharma vs Optimus Drugs Private Limited
slug_a: dipharma
slug_b: optimuspharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/dipharma/optimuspharma
---

# Dipharma vs Optimus Drugs Private Limited

Side-by-side profile data from each company listing on this directory.

## Dipharma

- Profile: [/companies/dipharma](/companies/dipharma)

Dipharma — Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.

Services: 6. Modalities: 1. Indications: 0. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- API Synthesis & Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Optimus Drugs Private Limited

- Profile: [/companies/optimuspharma](/companies/optimuspharma)

Optimus Drugs Private Limited — Leading CDMO delivering end-to-end small molecule drug substance and drug product development and manufacturing from clinical to commercial scale, with 21+ years of expertise and GMP-certified facilities.

Services: 11. Modalities: 1. Indications: 4. Locations: 1. Certifications: 4. The strongest documented coverage currently appears in services (11).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)